115 related articles for article (PubMed ID: 23598291)
21. TNF-like ligand 1A (TL1A) gene knockout leads to ameliorated collagen-induced arthritis in mice: implication of TL1A in humoral immune responses.
Wang X; Hu Y; Charpentier T; Lamarre A; Qi S; Wu J; Luo H
J Immunol; 2013 Dec; 191(11):5420-9. PubMed ID: 24140642
[TBL] [Abstract][Full Text] [Related]
22. Decoy receptor 3 expressed in rheumatoid synovial fibroblasts protects the cells against Fas-induced apoptosis.
Hayashi S; Miura Y; Nishiyama T; Mitani M; Tateishi K; Sakai Y; Hashiramoto A; Kurosaka M; Shiozawa S; Doita M
Arthritis Rheum; 2007 Apr; 56(4):1067-75. PubMed ID: 17393415
[TBL] [Abstract][Full Text] [Related]
23. Decoy receptor 3: a pleiotropic immunomodulator and biomarker for inflammatory diseases, autoimmune diseases and cancer.
Lin WW; Hsieh SL
Biochem Pharmacol; 2011 Apr; 81(7):838-47. PubMed ID: 21295012
[TBL] [Abstract][Full Text] [Related]
24. Involvement of TL1A and DR3 in induction of pro-inflammatory cytokines and matrix metalloproteinase-9 in atherogenesis.
Kang YJ; Kim WJ; Bae HU; Kim DI; Park YB; Park JE; Kwon BS; Lee WH
Cytokine; 2005 Mar; 29(5):229-35. PubMed ID: 15760679
[TBL] [Abstract][Full Text] [Related]
25. Interleukin‑12B is upregulated by decoy receptor 3 in rheumatoid synovial fibroblasts.
Fukuda K; Miura Y; Maeda T; Hayashi S; Kurosaka M
Mol Med Rep; 2016 Apr; 13(4):3647-52. PubMed ID: 26956410
[TBL] [Abstract][Full Text] [Related]
26. Decoy receptor 3 is highly expressed in patients with rheumatoid arthritis.
Hayashi S; Miura Y; Tateishi K; Takahashi M; Kurosaka M
Mod Rheumatol; 2010 Feb; 20(1):63-8. PubMed ID: 19821006
[TBL] [Abstract][Full Text] [Related]
27. Gene expression profiles of TNF-like cytokine 1A (TL1A) and its receptors death receptor 3 (DR3) and decoy receptor 3 (DcR3) in multiple sclerosis.
Basnyat P; Sumelahti ML; Lehtimäki T; Elovaara I; Hagman S
J Neuroimmunol; 2019 Oct; 335():577020. PubMed ID: 31445379
[TBL] [Abstract][Full Text] [Related]
28. Soluble decoy receptor 3 induces angiogenesis by neutralization of TL1A, a cytokine belonging to tumor necrosis factor superfamily and exhibiting angiostatic action.
Yang CR; Hsieh SL; Teng CM; Ho FM; Su WL; Lin WW
Cancer Res; 2004 Feb; 64(3):1122-9. PubMed ID: 14871847
[TBL] [Abstract][Full Text] [Related]
29. Gene polymorphisms and serum levels of TL1A in patients with rheumatoid arthritis.
Yuan ZC; Wang JM; Su LC; Xu WD; Huang AF
J Cell Physiol; 2019 Jul; 234(7):11760-11767. PubMed ID: 30488533
[TBL] [Abstract][Full Text] [Related]
30. Subclinical femoral atheromatosis in rheumatoid arthritis: comparable prevalence to diabetes mellitus in a case-control study.
Protogerou A; Zampeli E; Tentolouris N; Makrilakis K; Kitas G; Sfikakis PP
Ann Rheum Dis; 2012 Sep; 71(9):1534-6. PubMed ID: 22764043
[TBL] [Abstract][Full Text] [Related]
31. Specific elevation of DcR3 in sera of sepsis patients and its potential role as a clinically important biomarker of sepsis.
Kim S; Mi L; Zhang L
Diagn Microbiol Infect Dis; 2012 Aug; 73(4):312-7. PubMed ID: 22647538
[TBL] [Abstract][Full Text] [Related]
32. The association between carotid or femoral atherosclerosis and low bone mass in postmenopausal women referred for osteoporosis screening. Does osteoprotegerin play a role?
Pennisi P; Russo E; Gaudio A; Veca R; D'Amico F; Mangiafico RA; Laspina M; Tringali G; Signorelli SS; Fiore CE
Maturitas; 2010 Dec; 67(4):358-62. PubMed ID: 20727694
[TBL] [Abstract][Full Text] [Related]
33. Biochemical and structural characterization of the human TL1A ectodomain.
Zhan C; Yan Q; Patskovsky Y; Li Z; Toro R; Meyer A; Cheng H; Brenowitz M; Nathenson SG; Almo SC
Biochemistry; 2009 Aug; 48(32):7636-45. PubMed ID: 19522538
[TBL] [Abstract][Full Text] [Related]
34. DcR3 protects islet beta cells from apoptosis through modulating Adcyap1 and Bank1 expression.
Han B; Wu J
J Immunol; 2009 Dec; 183(12):8157-66. PubMed ID: 20007581
[TBL] [Abstract][Full Text] [Related]
35. Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis.
Dessein PH; Joffe BI; Singh S
Arthritis Res Ther; 2005; 7(3):R634-43. PubMed ID: 15899050
[TBL] [Abstract][Full Text] [Related]
36. Progression of human carotid and femoral atherosclerosis: a prospective follow-up study by magnetic resonance vessel wall imaging.
Bianda N; Di Valentino M; Périat D; Segatto JM; Oberson M; Moccetti M; Sudano I; Santini P; Limoni C; Froio A; Stuber M; Corti R; Gallino A; Wyttenbach R
Eur Heart J; 2012 Jan; 33(2):230-7. PubMed ID: 21920966
[TBL] [Abstract][Full Text] [Related]
37. Production of tumor necrosis factor and interleukin-1 by macrophages from human atheromatous plaques.
Tipping PG; Hancock WW
Am J Pathol; 1993 Jun; 142(6):1721-8. PubMed ID: 8506944
[TBL] [Abstract][Full Text] [Related]
38. Decoy receptor 3 attenuates collagen-induced arthritis by modulating T cell activation and B cell expansion.
Cheng CP; Sytwu HK; Chang DM
J Rheumatol; 2011 Dec; 38(12):2522-35. PubMed ID: 21885501
[TBL] [Abstract][Full Text] [Related]
39. Decoy strategies: the structure of TL1A:DcR3 complex.
Zhan C; Patskovsky Y; Yan Q; Li Z; Ramagopal U; Cheng H; Brenowitz M; Hui X; Nathenson SG; Almo SC
Structure; 2011 Feb; 19(2):162-71. PubMed ID: 21300286
[TBL] [Abstract][Full Text] [Related]
40. Decoy receptor 3 levels in peripheral blood predict outcomes of acute respiratory distress syndrome.
Chen CY; Yang KY; Chen MY; Chen HY; Lin MT; Lee YC; Perng RP; Hsieh SL; Yang PC; Chou TY
Am J Respir Crit Care Med; 2009 Oct; 180(8):751-60. PubMed ID: 19644047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
